1. 2508 Three-arm phase II randomized trial of docetaxel monotherapy or combined with ramucirumab or icrucumab in second-line locally advanced or metastatic urothelial carcinoma. (September 2015) Authors: Petrylak, D.P.; Tagawa, S.T.; Kohli, M.; Eisen, A.; Canil, C.; Sridhar, S.S.; Spira, A.; Yu, E.Y.; Burke, J.M.; Shaffer, D.; Pan, C.X.; Kim, J.J.; Aragon-Ching, J.B.; Tang, S.; Zhang, H.; Cavanaugh, C.T.; Kauh, J.S.; Walgren, R.A.; Chi, K.N. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S476 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗